Download Breakout Session Overviews | Download Schedule of Breakout Sessions | View Conference Schedule
Given the potential to resolve a large number of unmet clinical indications, there has been an increase in the number of clinical studies using stem cell therapies derived from Induced pluripotent stem cells (iPSC). iPSC are a type of pluripotent stem cell that can be generated from adult somatic cells. This talk will focus on the raw materials used in the manufacture of cellular therapies and their regulatory requirements. 513
Presenter: Anat Feldman, PhD, MBA, CCRP, MMgr, Business Development, Clinical Applications, STEMCELL Technologies Canada Inc.
Ms. Grewal will provide practical insights into the current state of this emerging area of medicine and research including but not limited to international regulatory review, study design considerations, and recruitment strategies. Additionally, Ms. Grewal will review target populations and discuss how cultural competency plays an important role when working with veteran, professional athletic, and first responder communities. 515
Presenter: Jaspreet Grewal, MSc, CCRP, CEO, Knowde Group, Inc.